This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Jakob Boegh Schubert
Introduction
Jakob Boegh Schubert is a notable inventor based in Graested, Denmark. He has made significant contributions to the field of medical devices, particularly in the design of needle assemblies. His innovative approach has led to the development of a unique safety mechanism that enhances the usability and safety of injection devices.
Latest Patents
Jakob Boegh Schubert holds a patent for a "Shieldable needle assembly with biased safety shield." This invention features a needle assembly designed for injection devices, which includes a needle cannula mounted in a hub that can connect to an injection device. The assembly incorporates a biasing shield that is telescopically guided relative to the hub. This design allows the needle cannula to be covered or exposed without visual contact during the injection process. Additionally, the assembly includes releasable locking means, enabling users to lock or unlock the shield for telescopic movement. The injection device itself can serve as the key for unlocking the shield, enhancing user convenience and safety.
Career Highlights
Jakob Boegh Schubert is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to focus on innovative solutions that improve patient outcomes and safety in medical treatments.
Collaborations
Jakob collaborates with Thibaud Hofstätter, contributing to the advancement of medical device technology through their combined expertise and innovative ideas.
Conclusion
Jakob Boegh Schubert's contributions to the field of medical devices, particularly through his patented needle assembly, demonstrate his commitment to enhancing safety and usability in healthcare. His work at Novo Nordisk continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
